Your trusted source for investing success

Tag: approval process

Top Gaining Cannabis IPOs

Top Gaining Cannabis IPOs

The marijuana sector in Canada is heating up, and a number of cannabis companies have performed well since going public. Here’s a brief overview of some of the top gainers.

Lexaria Announces R&D on Nicotine

Lexaria Announces R&D on Nicotine

Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the “Company,” “Lexaria”) is announcing new plans to commence nicotine absorption research beginning in the summer of 2017, within its previously announced R&D budget that is fully funded.

What Do Medical Device Companies Do?

What Do Medical Device Companies Do?

Medical devices will facilitate the life of doctors and patients by providing cutting edge technology through simple to use gadgets or machinery, we take a look at what these companies achieve and go through.

Lexaria Welcomes Canada’s Proposed Cannabis Legislation

Lexaria Welcomes Canada’s Proposed Cannabis Legislation

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) welcomes the newly proposed Canadian legislation designed to allow for adult legal access to Cannabis (the “Cannabis Act”). In line with the Cannabis Act’s objective to protect public health and public safety, powerful demographic and lifestyle forces are trending away from both the harmful effects related

Lexaria and NeutriSci Complete Cannabinoid Joint Venture

Lexaria and NeutriSci Complete Cannabinoid Joint Venture

Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) and NeutriSci International Inc. have completed and signed the previously announced joint venture agreement to produce and commercialize a line of healthy, sugar-free, edible cannabinoid mouth-melt products which will utilize Lexaria’s patented technology and Neutrisci’s proprietary pterostilbene tablet form factor.

Invictus MD’s Chairman Provides March in Review

Invictus MD’s Chairman Provides March in Review

INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s Cannabis Company, is pleased to provide a month in review.

March was a transformational time for Invictus MD as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of 50,000 kilograms of high quality cannabis production by

Lexaria Bioscience Closes Brokered Private Placement

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is pleased to announce that it has completed its previously announced brokered private placement of 4,104,280 units of the Company (“Units”) at a price per Unit of US$0.42 (the “Offering Price”), for total gross proceeds of US$1,723,798 (the “Offering”).

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network